Stada has significantly expanded its portfolio by acquiring a range of European consumer health brands following its recent acquisition by CapVest. This strategic move allows Stada to enhance its presence in the consumer health sector, particularly within European pharmacies, where the demand for over-the-counter products continues to grow. The acquisition comes at a time when many pharmaceutical companies are diversifying their offerings to include consumer health products, reflecting a broader industry trend towards integrated health solutions.
As Stada shifts its focus towards consumer health, Orifarm is simultaneously refining its strategy by concentrating on its pharmaceutical operations. This realignment indicates a potential shift in market dynamics, where companies are increasingly recognizing the value of specialized focus areas. For B2B professionals in regulatory, QA/QC, CMC, sourcing, and portfolio management, this development underscores the importance of agility in adapting to evolving market demands and the competitive landscape.
Use the database as your supply chain compass →
